Revenue Growth - Total revenues for the three months ended September 30, 2025, were $62,975,156, a significant increase from $28,148,491 for the same period in 2024, representing a growth of 123.8%[201]. - Life solutions revenue rose by $26,090,472, or 93.1%, for the three months ended September 30, 2025, compared to the same period in 2024, driven by increased realized gains[205]. - Life solutions revenue for the three months ended September 30, 2025, was $54,122,577, a 93.1% increase from $28,032,105 in 2024[249]. - For the nine months ended September 30, 2025, revenue increased to $25,168,756, a 4567.7% increase compared to $539,209 for the same period in 2024[244]. - Revenue from the asset management segment increased to $8,633,803 for the three months ended September 30, 2025, compared to $116,386 in 2024, representing a change of 7318.2%[239]. Income and Profitability - Operating income for the three months ended September 30, 2025, was $22,413,178, compared to $6,849,971 for the same period in 2024, marking a growth of 227.5%[202]. - Net income attributable to Abacus Global Management, Inc. for the three months ended September 30, 2025, was $7,075,348, compared to a net loss of $5,125,055 for the same period in 2024[202]. - Adjusted net income for the three months ended September 30, 2025, was $19,497,978, significantly higher than the adjusted net income of $9,947,038 for the same period in 2024, representing a year-over-year increase of approximately 96%[263]. - Adjusted EBITDA for the three months ended September 30, 2025, was $37,904,835, with an adjusted EBITDA margin of 60.2%, compared to an adjusted EBITDA of $16,666,306 and a margin of 59.2% for the same period in 2024[267]. - For the nine months ended September 30, 2025, the net income attributable to Abacus Global Management, Inc. was $29,298,620, compared to a net loss of $(5,703,817) for the same period in 2024[263]. Expenses and Costs - Total operating expenses for the three months ended September 30, 2025, were $32,906,280, up from $19,110,539 in the same period in 2024, reflecting increased operational activities[202]. - Cost of revenue for the same period rose to $10,132,030, reflecting a 986.5% increase from $932,556 in the prior year[245]. - General and administrative expenses (including stock-based compensation) increased by $14,500,083 or 35.0% for the nine months ended September 30, 2025 compared to the same period in 2024, mainly due to increases in payroll and legal fees[219]. - Sales and marketing expenses increased by $3,031,657 or 45.6% for the nine months ended September 30, 2025 compared to the same period in 2024, primarily due to higher advertising costs[217]. - Depreciation and amortization expense increased by $9,164,926 or 177.0% for the nine months ended September 30, 2025 compared to the same period in 2024, primarily related to the amortization of acquired businesses' intangible assets[221]. Asset Management and Investments - Assets under management as of September 30, 2025, totaled $2,906,540,011, reflecting an increase from the previous balance[241]. - Total assets under management as of September 30, 2025, reached $2,906,540,011, with inflows of $468,306,186 and outflows of $155,492,297[246]. - Longevity Funds experienced new subscriptions of approximately $71.0 million and outflows of approximately $16.3 million, resulting in a net change in value of approximately $50.5 million due to realized and unrealized gains[242]. - ETF Funds saw new subscriptions of approximately $31.1 million and outflows of approximately $9.3 million, leading to a net change in value of approximately $14.8 million from realized and unrealized gains[243]. - The number of policies serviced increased by 164.4% from 1,210 in 2024 to 3,199 in 2025[288]. Cash Flow and Financing - Cash and cash equivalents decreased from $131,944,282 at the end of 2024 to $86,418,953 by September 30, 2025[290]. - Net cash used in operating activities improved by $98,586,631, from $(116,827,478) in 2024 to $(18,240,847) in 2025[296]. - The company may seek additional equity or debt financing to support future capital requirements[291]. - The company approved repurchase plans totaling $50,000,000, with $— remaining available for repurchases as of September 30, 2025[292]. - Financing activities used $(13,305,337) of net cash during the nine months ended September 30, 2025, a decrease of $(125,120,928) compared to $111,815,591 provided in the same period in 2024[298]. Tax and Accounting - Income tax expense increased by $4,943,054 or 1974.3% for the three months ended September 30, 2025, compared to the same period in 2024[237]. - The estimated tax impact for the nine months ended September 30, 2025, is $11,096,742, compared to $2,803,760 in 2024, indicating a substantial increase in tax expenses[276]. - The company has not made any material changes to its critical accounting policies since the last Annual Report on Form 10-K[299]. - Recent accounting pronouncements and their future adoption are discussed in the Summary of Significant Accounting Policies and Recent Accounting Standards[300]. - The company is classified as a smaller reporting company and is not required to provide certain market risk disclosures[301].

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Motorsport Games Inc. (MSGM) has seen a substantial increase of 122%, trading at $4.88 [3] - Globus Medical, Inc. (GMED) is up 27%, currently priced at $78.75 [3] - JFrog Ltd. (FROG) has risen by 26%, trading at $59.60 [3] - FIGS, Inc. (FIGS) is up 19%, with a trading price of $8.97 [3] - Organogenesis Holdings Inc. (ORGO) has increased by 18%, trading at $4.59 [3] - PureCycle Technologies, Inc. (PCT) is up 17%, currently priced at $11.31 [3] - Expedia Group, Inc. (EXPE) has risen by 16%, trading at $255.10 [3] - 10x Genomics, Inc. (TXG) is up 13%, currently priced at $14.72 [3] - Abacus Global Management, Inc. (ABL) has increased by 12%, trading at $5.95 [3] - GigaCloud Technology Inc. (GCT) is up 9%, currently priced at $27.80 [3] Premarket Losers - Davis Commodities Limited (DTCK) has experienced a significant decline of 65%, trading at $2.23 [4] - Eledon Pharmaceuticals, Inc. (ELDN) is down 46%, currently priced at $2.19 [4] - Treace Medical Concepts, Inc. (TMCI) has decreased by 35%, trading at $4.00 [4] - Energys Group Limited (ENGS) is down 30%, currently priced at $2.77 [4] - Intellia Therapeutics, Inc. (NTLA) has seen a decline of 27%, trading at $8.89 [4] - Fox Factory Holding Corp. (FOXF) is down 24%, currently priced at $16.60 [4] - Opendoor Technologies Inc. (OPEN) has decreased by 24%, trading at $4.94 [4] - AirSculpt Technologies, Inc. (AIRS) is down 21%, currently priced at $8.27 [4] - Power Solutions International, Inc. (PSIX) has seen a decline of 20%, trading at $64.25 [4] - ClearPoint Neuro, Inc. (CLPT) is down 17%, currently priced at $15.00 [4]

Core Insights - Abacus Life, Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.18 per share, and matching the earnings from the previous year [1] - The company achieved revenues of $62.98 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 32.80% and significantly increasing from $28.15 million year-over-year [2] - The stock has underperformed, losing approximately 32.3% since the beginning of the year, while the S&P 500 has gained 15.6% [3] Earnings Performance - Abacus Life has surpassed consensus EPS estimates in all four of the last quarters [2] - The company had an earnings surprise of +11.11% for the latest quarter and a +37.5% surprise in the previous quarter [1][2] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.20 on revenues of $50.49 million, and for the current fiscal year, it is $0.79 on revenues of $198.29 million [7] - The Zacks Rank for Abacus Life is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Insurance - Life Insurance industry is currently ranked in the top 11% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]

Financial Data and Key Metrics Changes - Total revenue increased 124% year-over-year to $63 million, compared to $28.1 million in the prior year [4][20] - Adjusted net income rose 60% to $23.6 million, while adjusted EBITDA increased 127% to $37.9 million [4][23] - The company raised its 2025 guidance to a range of $80-$84 million, representing year-over-year growth of 72%-81% [4][24] Business Line Data and Key Metrics Changes - The Life Solutions segment benefited from a highly efficient origination platform and active trading division, contributing significantly to revenue growth [20] - The asset management segment generated $8.6 million in revenue during Q3, with $102 million of new inflows, demonstrating the value of strategic M&A activity [20] Market Data and Key Metrics Changes - Year-to-date, the company raised $468 million across all fund strategies, with Q3 inflows representing $102 million [9] - The average publicly traded alternative asset manager trades at roughly 20 times projected 2025 earnings, while the company trades in the mid-single digits, indicating a significant valuation disconnect [8] Company Strategy and Development Direction - The company initiated an annual dividend of $0.20 per share and a $10 million share repurchase program, reflecting confidence in its long-term strategy [4][5] - The acquisition of AccuQuote is expected to enhance competitive position and broaden origination and global wealth platforms [10][11] Management's Comments on Operating Environment and Future Outlook - Management emphasized the structural differentiation of longevity-based assets, which are uncorrelated to traditional markets, providing consistent exposure [11][12] - The company aims to increase recurring fee-based revenue, which commands higher valuations, and is committed to clear communication with investors [9][10] Other Important Information - The company achieved a major milestone with a $50 million above investment-grade securitization product note backed by life insurance assets, validating strong institutional demand [12][15] - The annualized adjusted return on equity was 22%, and the annualized adjusted return on invested capital was 21% for the quarter [23] Q&A Session Summary Question: Inquiry about securitization and additional economics - Management confirmed that they will retain servicing fees on the securitized assets, which will produce additional fee-related earnings [30] Question: Update on advertising efforts and KPIs - Management noted a 10% increase in Q3 revenue compared to the previous year, attributing success to increased advertising efforts [32] Question: Capital deployed and expectations for future capital deployment - Management indicated that $120 million is a reasonable run rate for future capital deployment, driven by increased demand from institutional investors [39] Question: Thoughts on the new dividend and capital allocation - Management explained that the dividend is a way to capitalize shareholders while still pursuing growth opportunities, with a conservative payout ratio [44][46] Question: Unit economics and revenue from securitization - Management stated that the unit economics from securitization are compelling and will provide consistency in profitability and margins over time [51][54] Question: Progress on Abacus Wealth Advisors and AUM goals - Management expressed confidence in the growth of the wealth advisory segment and highlighted the importance of being selective in acquisitions [56] Question: Realized gains and holding periods for policies - Management explained that longer holding periods for policies led to increased realized gains, and they aim to maintain a target of north of 20% for future gains [60][63]

Financial Performance - Total revenue for Q3 2025 reached $63.0 million, a 124% increase year-over-year from $28.1 million[3] - GAAP net income attributable to shareholders was $7.1 million, compared to a net loss of $5.1 million in the prior-year period[3] - Adjusted net income increased 60% year-over-year to $23.6 million, with adjusted diluted earnings per share at $0.24[3] - Adjusted EBITDA grew 127% year-over-year to $37.9 million, with an adjusted EBITDA margin of 60.2%[3] - Total revenues for Q3 2025 reached $62.98 million, a significant increase from $28.15 million in Q3 2024, representing a growth of 123.8%[22] - Net income for Q3 2025 was $7.08 million, a turnaround from a net loss of $5.28 million in Q3 2024, reflecting a positive change of $12.36 million[22] - Earnings per share for Q3 2025 were $0.07, compared to a loss of $0.07 per share in Q3 2024, indicating a positive shift in profitability[22] - For the three months ended September 30, 2025, adjusted net income was $23,608,143, compared to $14,719,496 for the same period in 2024, representing a year-over-year increase of 60.5%[23] - Adjusted EPS for the three months ended September 30, 2025, was $0.25 (basic) and $0.24 (diluted), compared to $0.20 (basic) and $0.20 (diluted) in 2024, indicating an increase of 25% in basic EPS[23] - Total revenue for the three months ended September 30, 2025, was $62,975,156, up from $28,148,491 in 2024, reflecting a growth of 123.7%[25] - Adjusted EBITDA for the three months ended September 30, 2025, was $37,904,835, compared to $16,666,306 in 2024, marking a significant increase of 127.6%[25] - The adjusted EBITDA margin for the three months ended September 30, 2025, was 60.2%, compared to 59.2% in 2024, showing a slight improvement[25] - For the nine months ended September 30, 2025, adjusted net income was $54,567,277, compared to $24,118,367 in 2024, representing an increase of 126.5%[24] Asset and Liability Management - The company reported total assets of $918.94 million as of September 30, 2025, up from $874.16 million at the end of 2024, marking an increase of 5.1%[21] - Current liabilities increased to $148.44 million in Q3 2025, compared to $62.47 million in Q4 2024, representing a rise of 137.5%[21] - The company’s total liabilities stood at $479.34 million as of September 30, 2025, compared to $450.87 million at the end of 2024, reflecting an increase of 6.3%[21] - The company’s cash and cash equivalents decreased to $86.42 million as of September 30, 2025, from $131.94 million at the end of 2024, a decline of 34.5%[21] Strategic Initiatives - Abacus completed the strategic acquisition of AccuQuote, enhancing its financial services platform[10] - The company sold $50 million in securitized life insurance assets, structured as an investment-grade rated collateralized note[10] - Abacus was added to the Russell 2000® and 3000® Indexes, effective September 22, 2025, enhancing visibility to institutional investors[10] Return on Investment - Annualized return on invested capital (ROIC) for Q3 2025 was 21% and annualized return on equity (ROE) was 22%[10] - Adjusted annualized ROIC for the period ended September 30, 2025, was 21%, up from 20% in 2024[26] - Adjusted annualized ROE for the period ended September 30, 2025, was 22%, slightly down from 23% in 2024[27] Revenue Breakdown - Life solutions revenue surged to $45.54 million in Q3 2025, compared to $28.03 million in Q3 2024, an increase of 62.6%[22]

Financial Performance - Q3 2025 - Gross revenue reached $63 million, a 124% increase year-over-year compared to $2814 million in Q3 2024[21, 72] - Adjusted Net Income was $236 million, up from $147 million in the prior-year period[21, 72] - Adjusted EBITDA increased to $379 million, compared to $167 million in the prior-year period[21, 72] - Capital deployed for policy purchases totaled $1024 million[21] - Assets Under Management (AUM) reached $33 billion[16, 21] Growth & Profitability - Year-over-year revenue growth was 124%[22] - Year-over-year growth in capital deployed was 10%[22] - Adjusted Annualized Return on Equity (ROE) was 22%[22] - Adjusted Annualized Return on Invested Capital (ROIC) was 21%[20, 22] - Adjusted EBITDA Margin was 60%[20, 22] Revenue Mix & Targets - Life Solutions contributed 84% of revenue year-to-date, with a 5-year target of 30%[24] - Asset Group contributed 15% of revenue year-to-date, with a 5-year target of 30%[20, 24] - Technology contributed less than 1% of revenue year-to-date, with a 5-year target of 10%[24] - Wealth Advisors had no revenue year-to-date, with a 5-year target of 30%[24] Abacus Asset Group - Capital inflows for the quarter were $713 million, bringing the year-to-date total to $3544 million[25, 50] - Management fees for the quarter were $86 million, with a year-to-date total of $219 million[25, 50] - The company is targeting over $4 billion in fee-paying AUM by the end of 2026[25] ABL Tech - ABL Tech is tracking over 26 million lives[25, 62] - ABL Tech experienced a 21x year-over-year increase in lives tracked[25, 60]

Core Insights - Abacus Global Management has announced an annual cash dividend of $0.20 per share, reflecting confidence in its long-term business model and capital strength [1][2] - The company plans to distribute up to 25% of adjusted net income or up to 55% of recurring revenue as dividends [1][2] - A $10 million share repurchase program has also been authorized as part of the capital allocation strategy [1][2] Financial Performance - The company reported record levels of cash generation and a strong balance sheet, supported by increasing capital inflows into longevity funds and growing fee income [2] - Recurring revenues are expected to approach 70% of total revenue over time, indicating a shift towards more stable income sources [2] Capital Allocation Strategy - The capital allocation strategy aims to balance investment in growth, technology, and acquisitions with returning capital to shareholders through dividends and share buybacks [2][7] - The Board of Directors will evaluate dividend opportunities based on operating cash flow, capital requirements, and strategic investment opportunities [7][8] Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, and technology innovations [9] - The company focuses on longevity-based assets and personalized financial planning, leveraging proprietary data analytics for optimized financial outcomes [9]

Core Insights - Abacus Global Management, Inc. reported strong financial performance for the third quarter of 2025, marking its tenth consecutive quarter of earnings growth, with total revenue reaching $63.0 million, a 124% increase year-over-year [1][3][2] - The company has raised its full-year 2025 outlook for adjusted net income to between $80 million and $84 million, reflecting a year-over-year growth of 72% to 81% [6][2] - Recent strategic acquisitions, including AccuQuote, and the issuance of a $50 million securitized asset-backed rated note, are expected to enhance the company's growth trajectory and asset management capabilities [2][11][12] Financial Performance - Total revenue for Q3 2025 was $63.0 million, up from $28.1 million in Q3 2024, driven by growth in Life Solutions and Longevity Funds segments [3][22] - GAAP net income was $7.1 million, compared to a net loss of $5.1 million in the prior year, primarily due to higher revenues [3][22] - Adjusted net income increased 60% year-over-year to $23.6 million, with adjusted diluted earnings per share at $0.24, up from $0.20 [3][22] - Adjusted EBITDA grew 127% year-over-year to $37.9 million, with an adjusted EBITDA margin of 60.2% [3][30] Capital and Liquidity - As of September 30, 2025, the company had cash and cash equivalents of $86.4 million and total assets of $918.9 million [5][31] - The company’s balance sheet policy assets totaled $424.7 million, indicating a strong asset base to support future growth [5][31] Strategic Initiatives - The acquisition of AccuQuote is expected to enhance Abacus's financial services platform and expand its client lifecycle coverage [11][12] - The recent issuance of a $50 million securitized asset-backed rated note is seen as a scalable funding mechanism for future growth [11][12] Outlook - The company anticipates continued strong performance, with adjusted net income growth projected between 72% and 81% for the full year 2025 compared to 2024 [6][2] - Abacus has been added to the Russell 2000® and 3000® Indexes, which is expected to enhance visibility and access to institutional investors [11][12]

Core Insights - Abacus Global Management successfully sold $50 million of securitized life insurance assets structured as an above investment-grade rated collateralized note, closing the transaction on October 22, 2025 [1] - The note offers a mid-single-digit yield, indicating strong institutional demand for longevity-based assets that provide diversification from traditional market exposures [2] - The transaction allows institutional investors, banks, and insurance companies to gain direct exposure to life insurance assets through an uncorrelated rated structure [1][2] Company Overview - Abacus Global Management is a leader in alternative asset management, specializing in longevity-based assets and personalized financial planning [3] - The company utilizes proprietary data analytics and decades of industry expertise to deliver innovative financial solutions for individuals and institutions worldwide [3]

Core Viewpoint - Abacus Global Management, Inc. is set to release its third quarter 2025 financial results on November 6, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results will be discussed in a conference call scheduled for 5:00 pm Eastern Time on the same day [2] - A live webcast of the conference call will be available on the company's investor relations website [2] - The dial-in numbers for the conference call are provided for both toll-free and international participants [2] Group 2: Company Overview - Abacus Global Management specializes in alternative asset management and offers data-driven wealth solutions, technology innovations, and institutional services [3] - The company focuses on longevity-based assets and personalized financial planning, utilizing proprietary analytics and actuarial expertise [3] - Abacus aims to deliver innovative solutions that optimize financial outcomes for both individuals and institutions globally [3]